Angeline Lyon, PhD, has recently accepted a position as an assistant professor of Chemistry and Biological Science in the Department of Chemistry at Purdue University. Angeline earned her PhD in 2009 under the direction of David Hoffman at the University of Texas at Austin. She then completed postdoctoral training under the direction of John Tesmer at the University of Michigan. Angeline was a previous winner of the ASPET Molecular Pharmacology postdoctoral oral presentation competition and is currently a member of the Molecular Pharmacology Executive Committee.

Her current research interests include understanding the molecular mechanisms regulating PLCβ and PLCε under basal and activating conditions. These studies incorporate biochemical and cell-based functional assays along with an innovative combination of X-ray crystallography and electron cryo-microscopy. Taken together, these studies will provide much needed insight into two key enzymes that contribute to cardiovascular function and disease, and will ultimately aid in the identification and development of novel therapeutics that modulate signaling by these enzymes.

Dr. Lyon has been an ASPET member since 2009.